BioPhorum Drug Substance’s Post

BioPhorum Drug Substance are hosting a showcase on our Life Cycle Management, Raw Materials and Continued Process Verification workstreams. The showcases will be held on 09 and 10 December. Session One - 09 December, 16:00 GMT Session Two - 10 December, 08:00 GMT Location - Online You can register using the links below. Session one - Register here: https://lnkd.in/ebSg5gDJ Session two - Register here: https://lnkd.in/eZiDNPMM In today’s biopharmaceutical landscape, efficiency and compliance are more critical than ever. This showcase event brings together industry experts to provide actionable insights into: - Life Cycle Management: How defining functional equivalence for equipment can support simplification of validation practices. - Raw Materials: Shaping the program for the next 5-years to harmonize the raw materials supply chain from suppliers to biomanufacturers. - Continued Process Verification: This community of practice meets several times a year to discuss hot topics relating to CPV and to share learnings on the extensive back catalogue of BioPhorum best practice guides on this topic. For further information about BioPhorum Drug Substance and to learn how you can become part of our community visit: https://lnkd.in/ejRyz9te #drugsubstance #connect #collaborate #accelerate

✨ Did you know that Poloxamer 188 has a long history of use as a shear protectant in the biopharma industry?    In biopharmaceutical manufacturing, the protection of cells from shear stress is of utmost importance. The most commonly used shear protectant, poloxamer 188, has a long history of use in the production of approved biologics. While the factors driving the need for shear protection are well known, there is still ongoing research to understand the critical parameters that control its performance. 🧪      At BASF Pharma Solutions, we understand the importance of providing your cells with the utmost protection, which is the reason why we offer    both Kolliphor® P188 Bio and Kolliphor® P188 Cell Culture as products in our family of compendial poloxamers. They are some of the highest quality and most controlled poloxamers available commercially.      🔍 How Much Protection Do Your Cells Need? Visit our website to learn more about how our poloxamers can support your upstream biopharma manufacturing process: https://lnkd.in/e8ymRUUj   #Biopharma #Pharma #Biotech #Biotechnology #Pharmaceuticals #cellculture #bioprocessing #BPIWest2024

📢 Exciting News! The October 2024 edition of Chemical Today Digital Magazine is Now Live! 🌐 This month, we’re diving into the Pharmaceutical Industry, highlighting the latest innovations, key trends, and expert insights that are driving the future of pharma. 💊✨ Don’t miss out—click the link below to read the Magazine! 👇 https://lnkd.in/g_fjKMUu To subscribe Digital Magazine https://lnkd.in/gSeMg-Ut #ChemicalToday #PharmaceuticalFocus #October2024Issue #PharmaInnovation #DigitalMagazine #IndustryInsights #pharmaindustry #pharmaceutical #chemicals #academics #worldofchemicals

Case Studies in Chemical Supply Chain Problem Solving ----------------------------------------------------- #3 Molybdate Salt, [MoO4]2 : Discover how NiCHe Materials revolutionized a pharmaceutical manufacturing process by delivering a once unattainable molybdate derivative on a large scale. #CaseStudy #Innovation #Pharmaceuticals"

LISURE buffer preparation systems will simplify buffer preparation and deliver qualified buffer as per the batch schedule. Let's connect to discuss further

Checkout Jim Calvino's article which explores the importance of a robust regulatory strategy and provides insights into how companies in the biotech and pharmaceutical sectors can leverage it to minimize risk and optimize success. Read the article on our website: https://ow.ly/tLIw50QVwyK #regulatory #biotech #pharmaceuticals #prestigescientific

How do peptide salts improve drug stability and bioavailability? Discover the latest innovations in peptide salt selection and characterization in our case study. 👉 Read now: https://ow.ly/lirL50THbQH #Pharmaceutical #StabilityTesting #ResearchAndDevelopment #DrugDevelopment

Saving time and money by prioritizing top drug candidates will always be top of mind during early #drugdevelopment. However, researchers must also consider long-term goals, whether seeing their drug through the regulatory approval process or licensing the drug to a biopharmaceutical company for further development. Read our quick ebook on strategically designing #ADME programs that align with your stage of development, meet your specific program’s goals, and take new global regulatory guidelines into account: https://lnkd.in/ehFvjwDj #druginteractions #drugmetabolism

I am excited to be at the contract pharma conference next week. If you’re attending, make sure to stop by Table 69 to chat and learn how Element can be your strategic testing partner. Feel free to message me and we can arrange a meeting during the event. See you there! #ElementLSinPharma #ContractPharma #Pharmaceutical #DrugDevelopment #Innovation #ConnectWithElement #Pharma #PharmTech #BioTech #RegulatoryCompliance

What collaborative efforts are essential for sustained success in the #cyclodextrin market amidst diverse factors like #pharmaceutical advancements and #sustainability demands? From #pharmaceutical advancements to sustainability demands, the cyclodextrin market thrives on diverse factors. To ensure sustained success, collaborative efforts among #manufacturers, #researchers, and regulatory bodies are crucial in overcoming challenges such as production costs, regulatory compliance, awareness, and competition, fostering a favorable #environment for cyclodextrin adoption and #innovation. Explore More Insights: https://lnkd.in/d7kt-Xzt Key Market Players: Cayman Chemical, CycloLabs, Wellona Pharma, Ligand Pharmaceuticals, Cyclo Therapeutics, Inc. #AMR #CyclodextrinMarket #IndustryGrowth #CollaborativeInnovation #Sustainability #Pharmaceuticals #ResearchInitiatives #ProductionEfficiency #RegulatoryCompliance #MarketAwareness #InnovationCollaboration